NLTX

Neoleukin Therapeutics (NLTX)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 8.2M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
1.10

Technicals

50-Day MA
13.8252
200-Day MA
14.9834
52 Week High
N/A
52 Week Low
N/A

About NLTX

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology.

Employees
7
Headquarters
Seattle, WA
CEO
Dr. Jonathan G. Drachman M.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg